What is the impact of capsule endoscopy in the long term period?

doi:10.4253/wjge.v8.i7.344

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8704)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

469

WORD

280

HTML

2848

Tables (1-4)

316

Sum=3913

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

569

Download

1347

Sum=1916

Publishing Process of This Article

Item

Count

Browse

1026

Download

1849

Sum=2875

Apr 10, 2016 (publication date) through Mar 13, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Apr 10, 2016; 8(7): 344-348
Published online Apr 10, 2016. doi: 10.4253/wjge.v8.i7.344

Table 3 Risk factors for rebleeding (univariate-multivariate analysis)

	Univariate			Multivariate
	OR	95%CI	P	OR	95%CI	P
Comorbidity	5.176	2.442-10.972	0.001^b	2.274	0.864-5.986	0.096
Age	3.400	1.574-7.342	0.001^b	1.735	0.595-5.057	0.313
Overt OGIB	2.659	1.265-5.589	0.015^a	1.222	0.490-3.048	0.667
NSAIDs-anticoagulant-antiagregant therapy	5.575	2.153-14.438	0.001^b	5.843	1.868-18.275	0.002^b
Vasculary lesion	6.458	2.852-14.625	0.001^b	6.027	2.568-14.146	0.001^b
Positive CE results	17.460	2.269-134.371	0.001^b	-	-	-

^aP < 0.05;

^bP < 0.01. OGIB: Obscure gastrointestinal bleeding; NSAIDs: Non-steroidal anti-inflammatory drugs; CE: Capsule endoscopy.

Citation: Ormeci A, Akyuz F, Baran B, Gokturk S, Ormeci T, Pinarbasi B, Soyer OM, Evirgen S, Akyuz U, Karaca C, Demir K, Kaymakoglu S, Besisik F. What is the impact of capsule endoscopy in the long term period? World J Gastrointest Endosc 2016; 8(7): 344-348
URL: https://www.wjgnet.com/1948-5190/full/v8/i7/344.htm
DOI: https://dx.doi.org/10.4253/wjge.v8.i7.344